MYC and neoplasm: Additionally, analysis of 10 tumor abnormality-related pathways revealed that pathways associated with malignant phenotypes (e.g., cell cycle, MYC signaling, PI3K signaling, and TP53 signaling) exhibit greater activation in cluster 2 than in cluster 1.